Effectiveness of drug Dhaturadi Tail on patients affected on Vipadika local

An Experimental Dermal Safety Study of Dhaturadi Tail in Rats and itâ??s Clinical Efficacy in Vipadika Through Local Application

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052913

Enrollment

Registered

2023-05-19

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere Health Condition 2: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere Health Condition 3: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

Intervention1: Dhaturadi Tail: Composition of Dhaturadi Tail-1.Dhatura beej 2.Mankand 3. Katu Tail. It cures vipadika. Duration-30 days. Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patients with clinical features of Vipadika according to Ayurveda and modern

Exclusion criteria

Exclusion criteria: Patients below 18 yr age and above 60 yr age, Having chronic skin manifestation like SLE. Patients having complaints for more than 5 yr.

Design outcomes

Primary

Measure	Time frame
Reduction of symptoms of Vipadika Pain-pada sphutana, VedanaTimepoint: First follow up after 7days	—

Secondary

Measure	Time frame
Reduction in symptoms - raga toda KanduTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr SRInchulkar

Shri N.P.A.Government Ayurveda College Raipur Chhattisgarh

sinchulkar@yahoo.co.in9425215318

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026